Results 81 to 90 of about 4,765 (219)

Prognostic value of MYD88/CXCR4 mutation allele fraction in Waldenström macroglobulinemia using a multiplex ddPCR assay

HemaSphere, Volume 10, Issue 6, June 2026.
Eleni Thanou, Ioannis Kollias, Eleni Kalafati, Christos Vlachos, Nefeli Mavrianou‐Koutsoukou, Ourania Theologi, Maria Sakkou, Christine Liacos, Konstantina Taouxi, Alexandra Papadimou, Katerina Chrisostomidou, Agisilaos Papadopoulos, Maria Gavriatopoulou, Evangelos Terpos, Evi Lianidou, Meletios A. Dimopoulos, Efstathios Kastritis, Athina Markou, Tina Bagratuni   +18 more
wiley   +1 more source

Machine learning enhances risk stratification and treatment failure prediction in diffuse large B‐cell lymphoma

HemaSphere, Volume 10, Issue 4, April 2026.
Abstract Diffuse large B‐cell lymphoma (DLBCL) is the most common lymphoma subtype worldwide. Existing prognostic models, including the National Comprehensive Cancer Network International Prognostic Index (NCCN IPI), rely on small predefined variable sets, discretized inputs, and do not incorporate longitudinal clinical histories or nonlinear ...
Mikkel Werling, Alexander D. Fuglkjær, Peter Brown, Carsten U. Niemann, Rudi Agius   +4 more
wiley   +1 more source

Fatal Non‐Hepatic Hyperammonemia Post‐Glofitamab: Ureaplasma and Genetic Susceptibility: A Case Report

Immunity, Inflammation and Disease, Volume 14, Issue 4, April 2026.
ABSTRACT Background Although primarily reported in solid organ transplant recipients and patients undergoing chimeric antigen receptor T‐cell immunotherapy (CAR‐T), non‐hepatic hyperammonemia (NHHA) is a rare but lethal complication in the broader context of post‐ chemo‐immunotherapy hematologic malignancies.
Yinshan Wu, Xiuliu Guo, Xiaoling Wang, Feng Guo   +3 more
wiley   +1 more source

Therapeutic targeting of MALT1 in oncology: Mechanism, inhibitor development, and clinical prospects

Journal of Cell Communication and Signaling, Volume 20, Issue 1, March 2026.
Abstract MALT1, a multifunctional protease molecule, plays a pivotal role in the adaptive immunity by regulating immune cell survival, proliferation and activation through the nuclear transcription factor‐κB (NF‐κB) signaling pathway by scaffold and protease activities.
Xintao Cao, Peixia Wang, Yuan Ji, Yongliang Sun, Dejiu Zhang   +4 more
wiley   +1 more source

IgM Myeloma or Waldenstrom\u27s Macroglobulinemia Is the Big Question? [PDF]

, 2014
: Although critical from therapeutic and prognostic perspectives, differentiating IgM Myeloma (MM) from Waldenstrom\u27s macroglobulinemia (WM) is fraught with failure.
Pant, S., Terjanian, T., Bhatt, V. R., Naqi, M., Kedia, S., Murukutla, S.   +5 more
core  

Bing–Neel syndrome, a rare manifestation of WM; a case report and review of literature

Clinical Case Reports
Key Clinical Message Bing–Neel syndrome (BNS) is a rare manifestation in individuals suffering from Waldenström macroglobulinemia (WM). Neurological signs and symptoms in this syndrome are almost difficult to be differentiated from other common ...
Hamid Rezvani, Sina Salari, Hamed Borhani, Maedeh Mataji, Hamed Azhdari Tehrani   +4 more
doaj   +1 more source

Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia

Nature Communications, 2018
Waldenström macroglobulinemia (WM)/lymphoplasmacytic lymphoma (LPL) is a non-Hodgkin-type B cell lymphoma. Here, the authors identify two risk loci for WM/LPL in a two-stage GWAS involving a family-oversampling approach and provide evidence for a ...
Mary L. McMaster, Sonja I. Berndt, Jianqing Zhang, Susan L. Slager, Shengchao Alfred Li, Claire M. Vajdic, Karin E. Smedby, Huihuang Yan, Brenda M. Birmann, Elizabeth E. Brown, Alex Smith, Geffen Kleinstern, Mervin M. Fansler, Christine Mayr, Bin Zhu, Charles C. Chung, Ju-Hyun Park, Laurie Burdette, Belynda D. Hicks, Amy Hutchinson, Lauren R. Teras, Hans-Olov Adami, Paige M. Bracci, James McKay, Alain Monnereau, Brian K. Link, Roel C. H. Vermeulen, Stephen M. Ansell, Ann Maria, W. Ryan Diver, Mads Melbye, Akinyemi I. Ojesina, Peter Kraft, Paolo Boffetta, Jacqueline Clavel, Edward Giovannucci, Caroline M. Besson, Federico Canzian, Ruth C. Travis, Paolo Vineis, Elisabete Weiderpass, Rebecca Montalvan, Zhaoming Wang, Meredith Yeager, Nikolaus Becker, Yolanda Benavente, Paul Brennan, Lenka Foretova, Marc Maynadie, Alexandra Nieters, Silvia de Sanjose, Anthony Staines, Lucia Conde, Jacques Riby, Bengt Glimelius, Henrik Hjalgrim, Nisha Pradhan, Andrew L. Feldman, Anne J. Novak, Charles Lawrence, Bryan A. Bassig, Qing Lan, Tongzhang Zheng, Kari E. North, Lesley F. Tinker, Wendy Cozen, Richard K. Severson, Jonathan N. Hofmann, Yawei Zhang, Rebecca D. Jackson, Lindsay M. Morton, Mark P. Purdue, Nilanjan Chatterjee, Kenneth Offit, James R. Cerhan, Stephen J. Chanock, Nathaniel Rothman, Joseph Vijai, Lynn R. Goldin, Christine F. Skibola, Neil E. Caporaso   +80 more
doaj   +1 more source

Waldenstrom's macroglobulinemia [PDF]

Blood, 1994
M A, Dimopoulos, R, Alexanian
openaire   +3 more sources

Macroglobulinemia de Waldenstrom presentada como un síndrome de hiperviscosidad

, 2013
La Macroglobulinemia de Waldenstrom es una rara enfermedad que se refiere a la producción de proteína monoclonal IgM acompañada de lifoma linfoplasmocitario demostrando en la médula ósea.
Salazar, Grace (dir)
core  

Penyakit Waldenstrom Makroglobulinemia

, 2016
Penyakit Waldenstrom Makroglobulinemia adalah kelainan limfoproliferatif sel B yang tidak umum, ditandai dengan infiltrasi sumsum tulang dan produksi immunoglobulin monoklonal IgM.
Wirawan, Riadi, Purnamasari, Endah
core   +1 more source